MUbio Products BV (MUbio) develops and manufactures high quality antibody reagents for cell biology and biomedical research, including cancer and stem cell research, according to strict ISO 9002 quality guidelines. A number of these antibodies have potential for use in cancer diagnosis.

In addition, in proprietary and partnered development programs MUbio is investigating, testing and validating patented antibodies and antigens for diagnostic applications and vaccination strategies in the field of lung cancer and cytomegalovirus (CMV).

All orders placed with MUbio are subject to the Customer's acception of the General Terms and Conditions of MUbio.